AMP-activated protein kinase deficiency reduces ozone-induced lung injury and oxidative stress in mice

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Hulo, Sébastien ^a,b   Tiesset, Hélène ^a,c   Lancel, Steve ^a   Louis Edmé, Jean J ^a,b   Viollet, Benoit ^d,e   Sobaszek, Annie ^a,b   Nevière, Rémi ^a  

^a UNIV LILLE   (France)

^b France Institut Pasteur de Lille   (France)

^c INSERM U1019   (France)

^d INSTITUT COCHIN   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MALONALDEHYDE; MYELOPEROXIDASE; OZONE; PEROXYNITRITE; POTASSIUM ION; SODIUM ION; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMPK ALPHA1 SUBUNIT, MOUSE; AUTACOID; PEROXIDASE; PEROXYNITROUS ACID;

ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CAGE; CELL COUNT; CONTROLLED STUDY; ENZYME SUBUNIT; EXPOSURE; LEUKOCYTE COUNT; LUNG CLEARANCE; LUNG HOMOGENATE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; PNEUMONIA; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LUNG; LUNG ALVEOLUS; LUNG EXTRAVASCULAR FLUID; METABOLISM; MOUSE MUTANT; TIME;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXTRAVASCULAR LUNG WATER; INFLAMMATION MEDIATORS; LUNG; LUNG INJURY; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; OZONE; PEROXIDASE; PEROXYNITROUS ACID; PHOSPHORYLATION; PNEUMONIA; PULMONARY ALVEOLI; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIME FACTORS;

EID: 79955993585     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-64     Document Type: Article

References (36)

1. Uysal N, Schapira RM. Effects of ozone on lung function and lung diseases. Curr Opin Pulm Med 2003, 9:144-150. 10.1097/00063198-200303000-00009, 12574695.
2. Laskin DL, Fakhrzadeh L, Laskin JD. Nitric oxide and peroxynitrite in ozone-induced lung injury. Adv Exp Med Biol 2001, 500:183-190.
3. Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EMG, Doorn JA, Slikker W. Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 2009, 112:4-16. 10.1093/toxsci/kfp179, 2769059, 19656995.
4. Liaudet L, Vassalli G, Pacher P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front Biosci 2009, 14:4809-4814. 2669439, 19273391.
5. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424. 10.1152/physrev.00029.2006, 2248324, 17237348.
6. Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007, 75:291-302. 10.1016/j.cardiores.2007.04.024, 17544386.
7. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007, 8:774-785. 10.1038/nrm2249, 17712357.
8. Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase--development of the energy sensor concept. J Physiol (Lond) 2006, 574:7-15.
9. Kim AS, Miller EJ, Young LH. AMP-activated protein kinase: a core signalling pathway in the heart. Acta Physiol (Oxf) 2009, 196:37-53.
10. Mark Evans A, Ward JPT. Hypoxic pulmonary vasoconstriction--invited article. Adv Exp Med Biol 2009, 648:351-360. 10.1007/978-90-481-2259-2_40, 19536499.
11. Ramamurthy S, Ronnett GV. Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J Physiol (Lond) 2006, 574:85-93.
12. Gusarova GA, Dada LA, Kelly AM, Brodie C, Witters LA, Chandel NS, Sznajder JI. Alpha1-AMP-activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta. Mol Cell Biol 2009, 29:3455-3464. 10.1128/MCB.00054-09, 2698765, 19380482.
13. Lancel S, Tissier S, Mordon S, Marechal X, Depontieu F, Scherpereel A, Chopin C, Neviere R. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol 2004, 43:2348-2358. 10.1016/j.jacc.2004.01.047, 15193704.
14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358. 10.1016/0003-2697(79)90738-3, 36810.
15. Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 1994, 16:149-156. 10.1016/0891-5849(94)90138-4, 8005510.
16. Planès C, Leyvraz C, Uchida T, Angelova MA, Vuagniaux G, Hummler E, Matthay M, Clerici C, Rossier B. In vitro and in vivo regulation of transepithelial lung alveolar sodium transport by serine proteases. Am J Physiol Lung Cell Mol Physiol 2005, 288:L1099-1109. 10.1152/ajplung.00332.2004, 15681398.
17. Fukuda N, Folkesson HG, Matthay MA. Relationship of interstitial fluid volume to alveolar fluid clearance in mice: ventilated vs. in situ studies. J Appl Physiol 2000, 89:672-679.
18. Litvan J, Briva A, Wilson MS, Budinger GRS, Sznajder JI, Ridge KM. Beta-adrenergic receptor stimulation and adenoviral overexpression of superoxide dismutase prevent the hypoxia-mediated decrease in Na,K-ATPase and alveolar fluid reabsorption. J Biol Chem 2006, 281:19892-19898. 10.1074/jbc.M602064200, 16636055.
19. Savov JD, Whitehead GS, Wang J, Liao G, Usuka J, Peltz G, Foster WM, Schwartz DA. Ozone-induced acute pulmonary injury in inbred mouse strains. Am J Respir Cell Mol Biol 2004, 31:69-77. 10.1165/rcmb.2003-0001OC, 14975936.
20. Hamade AK, Misra V, Rabold R, Tankersley CG. Age-related changes in cardiac and respiratory adaptation to acute ozone and carbon black exposures: interstrain variation in mice. Inhal Toxicol 2010, 22(Suppl 2):84-94.
21. Vadász I, Raviv S, Sznajder JI. Alveolar epithelium and Na,K-ATPase in acute lung injury. Intensive Care Med 2007, 33:1243-1251. 10.1007/s00134-007-0661-8, 17530222.
22. Hummler E, Planès C. Importance of ENaC-mediated sodium transport in alveolar fluid clearance using genetically-engineered mice. Cell Physiol Biochem 2010, 25:63-70. 10.1159/000272051, 20054145.
23. Rezaiguia S, Garat C, Delclaux C, Meignan M, Fleury J, Legrand P, Matthay MA, Jayr C. Acute bacterial pneumonia in rats increases alveolar epithelial fluid clearance by a tumor necrosis factor-alpha-dependent mechanism. J Clin Invest 1997, 99:325-335. 10.1172/JCI119161, 507800, 9006001.
24. Hardiman KM, McNicholas-Bevensee CM, Fortenberry J, Myles CT, Malik B, Eaton DC, Matalon S. Regulation of amiloride-sensitive Na(+) transport by basal nitric oxide. Am J Respir Cell Mol Biol 2004, 30:720-728.
25. Jain L, Chen XJ, Brown LA, Eaton DC. Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels. Am J Physiol 1998, 274:L475-484.
26. Han Y, Wang Q, Song P, Zhu Y, Zou MH. Redox regulation of the AMP-activated protein kinase. PLoS ONE 2010, 5:e15420. 10.1371/journal.pone.0015420, 2974634, 21079763.
27. Choi HC, Song P, Xie Z, Wu Y, Xu J, Zhang M, Dong Y, Wang S, Lau K, Zou MH. Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo. J Biol Chem 2008, 283:20186-20197. 10.1074/jbc.M803020200, 2459304, 18474592.
28. Xie Z, Dong Y, Zhang M, Cui MZ, Cohen RA, Riek U, Neumann D, Schlattner U, Zou MH. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. J Biol Chem 2006, 281:6366-6375. 10.1074/jbc.M511178200, 16407220.
29. Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S, Lantier L, Hebrard S, Devin-Leclerc J, Beauloye C, Foretz M, Andreelli F, Ventura-Clapier R, Bertrand L. AMPK: Lessons from transgenic and knockout animals. Front Biosci 2009, 14:19-44. 2666987, 19273052.
30. Almaça J, Kongsuphol P, Hieke B, Ousingsawat J, Viollet B, Schreiber R, Amaral MD, Kunzelmann K. AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated. Pflugers Arch 2009, 458:713-721. 10.1007/s00424-009-0660-4, 19333618.
31. Hallows KR. Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism. Curr Opin Nephrol Hypertens 2005, 14:464-471. 10.1097/01.mnh.0000174145.14798.64, 16046906.
32. Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol Rev 2009, 89:1025-1078. 10.1152/physrev.00011.2008, 19584320.
33. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 2007, 38:2992-2999. 10.1161/STROKEAHA.107.490904, 2637379, 17901380.
34. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005, 280:20493-20502. 10.1074/jbc.M409985200, 15772080.
35. Li J, McCullough LD. Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab 2010, 30:480-492. 10.1038/jcbfm.2009.255, 2852687,2852687, 20010958.
36. Zhao X, Zmijewski JW, Lorne E, Liu G, Park YJ, Tsuruta Y, Abraham E. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008, 295:L497-504. 10.1152/ajplung.90210.2008, 2536800,2536800, 18586954.